Purpose This study evaluates a pilot implementation of the Liverpool Care Pathway (LCP), a clinical tool used to guide the care of dying patients in the last days of life, on the end-oflife care for dying patients in three regions in rural Australia. Methods The LCP was implemented at 13 participating sites: nine hospitals (general wards), one community-based palliative care service, and three in-hospital palliative care units. To evaluate the implementation of the LCP, 415 eligible patient records were examined: 223 pre-implementation and 192 post-implementation (116 on the LCP and 76 receiving usual care). The primary analysis compared all patients preimplementation of the LCP versus all patients postimplementation.
Introduction
In Australia in 2010 and 2011, 52 % of deaths occurred in a hospital (including hospices affiliated with hospitals) [1] . Estimates suggest that almost three quarters of deaths could be anticipated [2] . However, one study found that that only 30 to 40 % of these patients had any contact with a specialist palliative care service [3] . Consequently, the majority of terminally ill patients are managed by non-specialist palliative care clinicians [4, 5] . The literature suggests that many non-palliative care clinicians lack experience in managing end-of-life symptoms. In addition, recognition of the dying phase often occurs very close to death (commonly only 24 to 48 h before death) and specialist palliative care input, particularly out of hours, is not always readily available [6, 7] .
Integrated care pathways (ICPs) are a popular strategy for fostering the use of evidence-based clinical practice guidelines and reducing medical errors [8, 9] . The Liverpool Care Pathway (LCP) is an end-of-life ICP based on the hospice model of care for use in the acute care setting. It was designed to improve the organisation and quality of palliative care in the last days of life through best practice comfort measures, symptom control, psychological and spiritual support, communication with family and the primary health care team, and documentation of the care provided [10, 11] . Previous studies have shown that end-of-life ICPs, particularly the LCP, are generally well regarded by health care professionals and are perceived to improve the care of dying patients, particularly with regard to symptom control, communication and documentation of care [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . The LCP is now used in over 20 countries worldwide [27] .
Nevertheless, the evidence supporting the LCP's effectiveness in obtaining a good death remains equivocal [28] [29] [30] [31] . For example, in the only cluster randomised trial of the LCP, Constantini et al. [32] found improvements in dignity, respect, kindness and the control of breathlessness, and an increased use of opioids and medications for pulmonary secretions. However, they found no significant difference in overall quality of care toolkit scores between cancer patients who died in wards in which LCP had been implemented and those in which it had not.
Recent well-publicised instances where end-of-life ICPs appear to have been misused have created controversy around the LCP in the UK [33] [34] [35] . An independent review of the public's concerns about the LCP concluded that, when applied correctly, the LCP helps generalist clinicians provide a dignified and pain-free death to their patients, supporting the principles underpinning the guidelines. Nevertheless, the questions raised by the inquiry resulted in the panel recommending that the LCP be replaced by an individualised end-of-life care plan for each patient [36] . This study aimed to evaluate changes in the use of diagnostic and therapeutic interventions, clinical assessments and communication by health professionals with other clinicians, patients and families in a heterogeneous sample of patients in rural Western Australia (WA).
Methods
A team of senior general and palliative care nurses, doctors and managers collaborated to modify the LCP version 11 for the WA context. With the permission of its originators, the hospital, hospice, community and care home versions of the LCP were standardised, and minor amendments were made to the terminology to address the cultural differences. For example, goal 6 was modified from discussing chaplain/religious advisors (original version 11) to spiritual/religious advisors in the WA version. The modified LCP was then piloted in four palliative care services in urban WA to determine its suitability to WA and to inform the future state-wide implementation. Initial feasibility work conducted prior to the evaluation highlighted the need for a systematic approach to implementation, with training support for service providers throughout the intervention period. The results reported here are derived from a second-phase implementation of the LCP in 13 health care sites in rural WA. Specific comparisons were performed between patients who died in hospitals in the 11 months prior to the implementation of the LCP (pre-LCP) and patients who died while on the LCP in the first 7 months after the implementation of the LCP, e.g. post-LCP and a contemporaneous cohort of patients who died in the same seven months post-implementation, but were not formally cared for on the LCP (not-LCP).
The intervention was managed by a centralised group of experts and coordinated through the WA Department of Health's Palliative Care Network to ensure up to date, consistent and ongoing education of providers, support and guidance during implementation. ). Due to the potential for causing distress for the patient prior to death and bereaved family members after the death, the ethics committees granted approval to waive consent.
Setting As a pragmatic capacity building project, all rural health services, including palliative care providers which had not previously used the LCP, were invited to participate. Thirteen sites agreed to take part in the pilot: nine community hospitals, one community palliative care service and three in-hospital palliative care units. All patients who were expected to die within 72 h at participating sites were the target for the intervention. Eligible patients (i.e. those identified as dying by clinical staff), in collaboration with their families (where appropriate), were offered the opportunity to be cared for according to the LCP. Only one patient refused the LCP and was cared for using standard practices. Patients in the post-Not-LCP group were cared for using 'standard care' and were included in the medical record data abstraction based on study eligibility. However, due to limitations of staff in these rural communities, patients in the LCP and Not-LCP groups were often cared for by the same clinical teams.
Determination of LCP and Not-LCP patients As recommended by the developers of the LCP, introduction of the LCP was left to the discretion of the most senior clinician managing each patient [11] . As a result, some patients who died in the demonstration wards were not offered the LCP. While we were unable to collect observational data on team interaction regarding commencing the LCP, anecdotal information from the clinicians involved suggested that reasons for this included the following: (1) disagreement within the clinical team as to whether the patient was dying, (2) a last attempt at rescue before offering the LCP, or (3) clinical overestimation of survival time left to the patient. This cohort of patients thus formed a 'natural' contemporaneous comparison group which served as our control (Not-LCP).
Implementation The project used a participatory action research approach [37] and the Plan-Do-Study-Act quality improvement implementation methodology [38] . A multidisciplinary 'train the trainer' approach was adopted with a minimum of two senior nurses from each site to manage the implementation. Three methods of collaboration were used to train health professionals in quality improvement techniques and the LCP: (1) three structured training sessions (14 h total) conducted over 12 months for both site champions and other participating health professionals; (2) monthly 'coaching' telephone, video conference calls or site visits by the implementation team to address concerns with the LCP implementation and to provide support; and (3) monthly quality improvement data collection and feedback to teams on performance in implementing changes in practice based on the LCP goals of care. Training focused on clinical aspects of end-oflife care, communication skills development between clinicians and patients and family members with clinicians, and education on the clinical use of the LCP. A palliative care resource kit was provided to the LCP champions at the first training session [39] .
Data collection Information regarding all care provided during the last hospitalisation was extracted from the medical records of eligible patients. All treatment and procedure items were classified according to broad therapeutic categories and the expected direction of changes in outcomes as a result of the use of the LCP were identified by a panel of palliative care clinicians (two physicians, two nurses and one pharmacist) and the research team (Table 1) .
Sample size Sample size was constrained by the number of eligible deaths at the selected sites. A sensitivity power analysis showed that at the 5 % significance level, the available data was sufficient to provide at least 80 % power to detect a 10 % difference for the comparison between preimplementation and post-implementation samples.
Data analysis
The primary outcome measures were as follows: utilisation of invasive medical investigations/interventions, symptom management and assessment, and communication with patient/family and among health professionals.
Outcome variables were dichotomous (i.e. yes/no) with patients deemed as having a procedure (yes) if there was documentation in the medical records of that procedure having ↑ expected increase in use of this therapy or aspect of care; ↓ expected decrease in use of this therapy or aspect of care; → use of this therapy or aspect of care expected to remain constant been conducted within 72 h of death. Chi-squared analyses were used to assess between-group differences. The primary analysis was all patients pre-implementation of the LCP versus all patients post-implementation. Secondary analyses were undertaken to assess the effect of the formal use of the LCP compared to being cared for by staff who may have received the LCP training without using the LCP formally. These involved comparing pre-LCP versus LCP, pre-LCP versus postnot-LCP, and LCP versus post-not-LCP. Differences in baseline characteristics were assessed by examining descriptive statistics such as frequencies, means and standard deviations, or medians and interquartile ranges, as appropriate. All analyses were performed using SPSS version 17 or higher.
Results
There were 415 eligible deaths over the data collection period. Of these, 223 occurred in the pre-LCP period and 192 in the post-implementation period. Of the post-implementation deaths, 116 (60 %) were cared for using the LCP and 76 (40 %) received 'usual' care (not-LCP group).
Patient characteristics The mean age of patients was 77.1 years (95 % CI 76.0 to 78.3), and the majority were male (54 %) and had a non-cancer diagnoses (63 %) ( Table 2) . On average, patients were hospitalised for 11.9 days prior to death (95 % CI 10.1 to 13.4), with 59 % having a length of stay of less than 1 week. More patients died of non-cancer illnesses in the LCP and not-LCP groups than in the pre-LCP group (69 and 58 vs 54 %; p=0.023). Deaths were not evenly distributed between the sites during the study period. The number of deaths per site ranged from 1 to 54 in the preimplementation period and 1 to 45 in the postimplementation period, with substantial differences between the pre-and post-implementation periods at some sites. For example, one of the larger sites contributed 29 cases to the pre-LCP group, but only 16 to the post-implementation cohorts: 2 in the LCP group and 14 in the not-LCP group. Five sites contributed ≤5 cases to the LCP group, and nine sites contributed ≤5 cases each to the not-LCP group.
Length of time on the LCP For patients cared for on the LCP, the mean number of days on the LCP prior to death was 4.2 days (95 % CI 3.4 to 4.9; median 3 days, IQ range 4). Mean length of time on the LCP for cancer patients was 3.8 days (95 % CI 2.9 to 3.7) while for non-cancer patients, mean length of time on the LCP was 4.4 days (95 % CI 3.2 to 5.7). These differences were not significant.
Overall comparison of use of interventions pre-and postimplementation of LCP Communication with family members and other clinicians (p≤0.001), routine symptom assessment (p≤0.001) and pre-emptive prescribing of end-of-life medications (p≤0.001) improved in all patients in the postimplementation period (Table 3) .
Comparison of use of interventions pre-LCP and LCP Use of venous access devices (p=0.017), blood investigations (p=0.018) and radiological investigations or treatments (p=0.012) were lower in the LCP group when compared to the pre-LCP group. In addition, routine symptom assessment (p=0.006), pre-emptive prescribing of end-of-life medications (p=0.001) and communication with family and other clinicians (p≤0.001) were higher in the LCP group (Table 4) . 
Comparison of use of interventions in post cohorts
The use of venous access devices (p=0.001), blood investigations (p= 0.011) and radiology investigations (p=0.037) were lower in the LCP group than in the not-LCP group (Table 5) . Contrary to expectations, the use of oxygen appears higher in the not-LCP group than in the LCP group. Conversely, communication, ongoing symptom assessments and the use of palliative medications were not significantly different between the LCP and not-LCP groups.
Comparison of use of interventions pre-LCP versus not-LCP The comparison between the pre-LCP and the not-LCP groups showed no substantive reduction in invasive medical procedures. In particular, there were no significant differences in the use of venous access devices, blood or radiology investigations (Table 6 ). However, communication with family and other clinicians (p≤0.001), ongoing symptom assessments (p=0.001) and use of palliative medications (p=0.003) were significantly higher in the not-LCP group.
Discussion
We evaluated changes in the use of diagnostic and therapeutic interventions, clinical assessments and communication by health professionals with other clinicians, patients and families when the LCP was introduced into multiple health services in rural Western Australia. We found that the overall training program and implementation of the LCP resulted in an increase in communication with family members and other clinicians, routine symptom assessment, and pre-emptive prescribing of end-of-life medications. We also found that the formal implementation of the LCP and care of patients using the LCP document resulted in a decrease in the use of invasive medical procedures and an increase in the documentation of assessments, coupled with an increase in the use of palliative medications. The LCP is intended to reduce the number of inappropriate or unnecessary procedures and treatments while increasing appropriate endof-life care. These findings suggest that there was an overall improvement in end-of-life care, with a strong focus on symptom relief. From this perspective, the implementation in WA was successful in achieving the goals of the LCP. Consistent with expectations, three important domains of potential active treatment (use of venous access devices, blood investigations and radiology investigations) were significantly lower in the LCP group than in the pre-LCP and not-LCP groups. On the other hand, the not-LCP group did not differ significantly from the pre-LCP group on these domains. This suggests that the difference between the LCP and not-LCP groups were not due to any secular or seasonal trends. Contrary to expectations, however, communication, ongoing assessments and the use of palliative medications increased not only in the LCP group but also in the not-LCP patients.
The use of oxygen therapy appeared to be substantially higher in the not-LCP group than in the LCP group. This was also the case when the not-LCP group was compared to the pre-LCP group, although this difference did not meet the standard for statistical significance. On the other hand, the LCP group did not differ significantly from the pre-LCP on this domain. This finding, therefore, may be an anomaly resulting from small numbers.
The current research literature shows some improvement in the care of the dying when using the LCP, particularly as a result of the structured prompts for the goals of care. In our study, 60 % of post-implementation deaths were cared for on the LCP. Previous studies report variable usage of the LCP ranging from 34 to 87 % [16, 17, [22] [23] [24] [25] . Patients on the LCP in this study were cared for using the LCP for an average of 4.2 days (median 3 days), with no difference in length of time Finally, participating sites in our study had no previous experience of the LCP and, apart from the three dedicated palliative care units, had no specialist palliative care support. Training in the use of the LCP and support for its implementation used a standardised approach provided centrally by palliative care clinical training experts with the support of the WA Country Health Service.
Strengths and limitations of the study This study aimed to address some of the methodological issues encountered by previous research. First, our study evaluated the LCP as it was implemented in practice within the state health services, using a quality improvement training process that supported providers throughout the demonstration with continuous education, quality improvement problem-solving techniques and monthly coaching calls to address problems in the field. Second, we used a pre-/post-intervention design with an added contemporaneous comparison group of patients who died within these organisations during the intervention period but did not receive the intervention. This design allowed for the evaluation of any secular trends in clinical care that could have influenced the implementation of the LCP. This comparison group provides added efficacy to the evaluation design. Third, while much of the LCP literature focuses on cancer deaths, this study included patients dying from both cancer and noncancer diagnoses and was conducted over multiple types of service providers and care settings. Finally, our study focused on relevant clinical care processes directed at dying patients, looking for improvements in individual patient outcomes that would be clinically and personally meaningful to both patients and their families.
Nevertheless, our study also has limitations. First, participants were not randomised to intervention and/or control groups. This was due to the fact that the study was an evaluation of the LCP as implemented at specific sites, which were determined by the WA Department of Health. As a result, randomisation was not practical or feasible. Therefore, a pre-/post-intervention design, together with a contemporaneous control cohort and quality improvement implementation process, was used to address the clinical and service delivery questions identified in this study. Under the circumstances, we believe that this was the best design that was achievable.
Second, we relied upon patient records to ascertain the care provided to patients. Medical record review is highly dependent on the accuracy, completeness and legibility of patient records. A particular focus of the LCP is the documentation of care. Thus, some outcomes, particularly communication, may have been underreported in the pre-and not-LCP groups. However, most outcomes of interest in this study, i.e. clinical care and procedures or investigations in the last days of life, require specific data documented in the patient's medical record. The alternative would have been to rely on carers' or bereaved family members' recall of care provided to the patients in the last days of life. Such recall is subject to response and recall bias and is likely to be less accurate than the written record in the patients' files.
Third, our study was set in sparsely populated rural areas, in which the availability of intensive invasive procedures may have been limited. Therefore, the findings may not be generalisable to all rural or to urban settings nor to improved health service delivery system-wide. Furthermore, the sparseness of the population meant that no single site had a sample size that was sufficient to assess the implementation of the LCP. Even after collecting all available data from 13 sites, the overall number of eligible deaths in the reference periods was lower than anticipated. These differences can be attributed to the fact that the number of deaths at a given site in a given period cannot be accurately predicted. As a result, there was insufficient statistical power to control for differences in care practices across sites or for different diagnoses, in the naive analysis presented here. The results should therefore be interpreted with caution, pending more sophisticated statistical modelling.
Finally, while extensive efforts were made throughout the implementation period to support and educate clinicians on the appropriate use of the LCP, we were unable to directly assess the manner in which the LCP was interpreted and then applied by the clinical teams in the implementation organisations. Based on the intensive quality improvement education sessions conducted over the course of the demonstration, the assumption was made that the LCP was implemented approximately the same way across all the sites.
New interventions need to be critically evaluated to assess benefits and risks; nevertheless, innovation is necessary to meet the challenges of providing optimal care for the dying in the future [40] . The WA Health Department addressed this dilemma by first pilot testing the LCP in four palliative care settings before testing the LCP in the larger project in the 13 rural settings reported here. However, this study does not address some of the major unanswered questions in the literature. These include developing a firmer understanding of the content and process of the clinical team discussions initiating the LCP (e.g. clinical team discussions; communication with the family) as well as a better understanding whether it is the content of the LCP training itself or the quality improvement implementation process that contributes most to the successful implementation of the pathway.
Conclusion
This study supports the conclusion that a structured, centralised and directed implementation of the LCP can be successful in improving important aspects of clinical and supportive care during the last days and hours of life.
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